News NICE backs Bayer's Xarelto in new stroke and heart attack pr... Bayer’s Xarelto (rivaroxaban) can be funded by the NHS to prevent strokes and heart attacks in high-risk adults with coronary artery disease, NICE has said.
News NICE expands funding for AstraZeneca's high potassium drug NICE has recommended extended funding on the NHS for AstraZeneca’s high potassium drug Lokelma in final draft guidance.
News Tarsus places $800m wager on Alkeus' Stargardt therapy Tarsus agrees to buy Alkeus in an $800m deal that will give it rights to a drug for eye disorder Stargardt disease with "blockbuster potential."
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
